Top

Published in:

Open Access 01-02-2019

Effects of age, HIV, and HIV-associated clinical factors on neuropsychological functioning and brain regional volume in HIV+ patients on effective treatment

Authors: Natalia Gawron, M. Choiński, B. Szymańska-Kotwica, A. Pluta, M. Sobańska, A. R. Egbert, A. Desowska, T. Wolak, A. Horban, E. Firląg-Burkacka, P. Bieńkowski, H. Sienkiewicz-Jarosz, A. Scińska-Bieńkowska, B. Biswal, S. M. Rao, R. Bornstein, E. Łojek

Published in: Journal of NeuroVirology | Issue 1/2019

Abstract

It is yet unclear if people infected with human immunodeficiency virus (HIV+) on stable, combined antiretroviral therapies (cARTs) decline with age at the same or greater rate than healthy people. In this study, we examined independent and interactive effects of HIV, age, and HIV-related clinical parameters on neuropsychological functioning and brain regional volume in a sizable group of Polish HIV+ men receiving cART. We also estimated the impact of nadir CD4 cell count, CD4 cell count during participation in the study, duration of HIV infection, or duration of cART along with age. Ninety-one HIV+ and 95 control (HIV−) volunteers ages 23–75 completed a battery of neuropsychological tests, and 54 HIV+ and 62 HIV− of these volunteers participated in a brain imaging assessment. Regional brain volume in the cortical and subcortical regions was measured using voxel-based morphometry. We have found that HIV and older age were independently related to lower attention, working memory, nonverbal fluency, and visuomotor dexterity. Older age but not HIV was associated with less volume in several cortical and subcortical brain regions. In the oldest HIV+ participants, age had a moderating effect on the relationship between the duration of cART and visuomotor performance, such as that older age decreased speed of visuomotor performance along with every year on cART. Such results may reflect the efficacy of cART in preventing HIV-associated brain damage. They also highlight the importance of monitoring neuropsychological functioning and brain structure in HIV+ patients. This is particularly important in older patients with long adherence to cART.

Available only for authorised users

Ances BM, Ortega M, Vaida F, Heaps J, Paul R (2012) Independent effects of HIV, aging, and HAART on brain volumetric measures. J Acquir Immune Defic Syndr 59(5):469–477. https://doi.org/10.1097/QAI.0b013e318249db17 CrossRefPubMedPubMedCentral

Appay V, Fastenackels S, Katlama C, Ait-Mohand H, Schneider L, Guihot A, Keller M, Grubeck-Loebenstein B, Simon A, Lambotte O, Hunt PW, Deeks SG, Costagliola D, Autran B, Sauce D (2011) Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients. AIDS 25(15):1813–1822. https://doi.org/10.1097/QAD.0b013e32834640e6 CrossRefPubMed

Basso MR, Bornstein RA (2000) Estimated premorbid intelligence mediates neurobehavioral change in individuals with HIV across 12 months. J Clin Exp Neuropsychol 22:208–218CrossRefPubMed

Becker JT, Kingsley LA, Molsberry S, Reynolds S, Aronow A, Levine AJ, Martin E, Miller EN, Munro CA, Regin A, Saktor N, Selnes OA (2015) Cohort profile: recruitment cohorts in the neuropsychological substudy of the multicenter AIDS cohort study. Int J Epidemiol 44(5):1506–1516. https://doi.org/10.1093/ije/dyu092 CrossRefPubMed

Brzeziński J, Gaul M, Hornowska E, Jaworowska A, Machowski A, Zakrzewska M (2004) Wechsler Adult Intelligence Scale – Revised. Psychological Test Laboratory of the Polish Psychological Association, Warsaw

Cardenas VA, Meyerhoff DJ, Studholme C, Kornak J, Rothlind J, Lampiris H, Neuhaus J, Grant RM, Chao LL, Truran D, Weiner MW (2009) Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treatedwith antiretroviral therapy. J Neuro-Oncol 15(4):324–333. https://doi.org/10.1080/13550280902973960 CrossRef

Clark US, Cohen RA (2010) Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals. Curr Opin Investig Drugs 11(8):884–900PubMedPubMedCentral

Coban H, Robertson K, Krishnan S, Wu K, Bosch RJ, Collier AC, Ellis RJ (2017) Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen. AIDS 31(11):1565–1571. https://doi.org/10.1097/QAD.0000000000001523 CrossRefPubMed

Cohen RA, Harezlak J, Schifitto G, Hana G, Clark U, Gongvatana A, Paul R, Taylor M, Thompson P, Algers J, Brown M, Zhong J, Campbell T, Singer E, McMahon D, Tso Y, Yiannoutsos CT, Navia B, and the HIV Neuroimaging Consortium (2010) Effects of nadir CD4 count and duration of HIV infection on brain volumes in the HAART era. J Neuro-Oncol 16(1):25–32. https://doi.org/10.3109/13550280903552420 CrossRef

Corrêa DG, Zimmermann N, Tukamoto G, Doring T, Ventura N, Leite SC, Cabral RF, Fonseca RP, Bahia PR, Gasparetto EL (2016) Longitudinal assessment of subcortical gray matter volume, cortical thickness, and white matter integrity in HIV-positive patients. J Magn Reson Imaging 44(5):1262–1269. https://doi.org/10.1002/jmri.25263 CrossRefPubMed

Corsi PM (1972) Human memory and the medial temporal region of the brain. Diss Abstr Int 34:891B

Costagliola D, Lacombe JM, Ghosn J, Delaugerre C, Pialoux G, Cuzin L, Launay O, Ménard A, de Truchis P, Mary-Krause M, Weiss L, Delfraissy JF (2014) CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppression. J Int AIDS Soc 17(4 Suppl 3):19481. https://doi.org/10.7448/IAS.17.4.19481. eCollectionCrossRefPubMedPubMedCentral

Crum Cianflone NF, Moore DJ, Letendre S, Poehlman Roediger M, Eberly L, Weintrob A, Ganesan A, Johnson E, Del Rosario R, Agan BK, Hale BR (2013) Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons. Neurology 80:371–379. https://doi.org/10.1212/WNL.0b013e31827f0776 CrossRefPubMedPubMedCentral

Cysique LA, Maruff P, Bain MP, Wright E, Brew BJ (2011) HIV and age do not substantially interact in HIV-associated neurocognitive impairment. J Neuropsychiatr Clin Neurosci 23(1):83–89. https://doi.org/10.1176/appi.neuropsych.23.1.83 CrossRef

Cysique LA, Heaton RK, Kamminga J, Lane T, Gates TM, Moore DM, Hubner E, Carr A, Brew BJ (2014) HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research. J Neurovirol 20(3):258–68. https://doi.org/10.1007/s13365-014-0242-x

Cysique LA, Soares JR, Geng G, Scarpetta M, Moffat K, Green M, Brew BJ, Henry RG, Rae C (2017) White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration. J Neuro-Oncol 23(4):539–547. https://doi.org/10.1007/s13365-017-0524-1 CrossRef

Egbert AR, Biswal B, Karunakaran K, Gohel S, Pluta A, Wolak T, Szymańska B, Firląg-Burkacka E, Sobańska M, Gawron N, Bieńkowski P, Sienkiewicz-Jarosz H, Ścińska-Bieńkowska A, Bornstein R, Rao S, Łojek E (2018) Age and HIV effects on resting state of the brain in relationship to neurocognitive functioning. Behav Brain Res 344:20–27. https://doi.org/10.1016/j.bbr.2018.02.007 CrossRefPubMed

Ellis RJ, Badiee J, Vaidaa F, Letendre S, Heaton RK, Clifford D, Collier AC, Gelman B, McArthur J, Morgello S, McCutchana JA, Grant I, for the CHARTER Group (2011) CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS 25(14):1747–1751. https://doi.org/10.1097/QAD.0b013e32834a40cd CrossRefPubMed

European Centre for Disease Prevention and Control/WHO Regional Office for Europe (2017) HIV/AIDS surveillance in Europe 2017 – 2016 data. ECDC, Stockholm

Fischl B (2012) FreeSurfer. NeuroImage 62(2):774–781. https://doi.org/10.1016/j.neuroimage.2012.01.021 CrossRefPubMed

Gelman BB (2015) Neuropathology of HAND with suppressive antiretroviral therapy: encephalitis and neurodegeneration reconsidered. Curr HIV/AIDS Rep 12:272–279. https://doi.org/10.1007/s11904-015-0266-8 CrossRefPubMedPubMedCentral

Guha A, Brier MR, Ortega M, Westerhaus E, Nelson B, Ances BM (2016) Topographies of cortical and subcortical volume loss in HIV and aging in the cART era. J Acquir Immune Defic Syndr 73(4):374–383. https://doi.org/10.1097/QAI.0000000000001111 CrossRefPubMedPubMedCentral

Haaland K, Cleeland C, Carr D (1977) Motor performance after unilateral hemisphere damage in patients with tumor. Arch Neurol 34:556–559. https://doi.org/10.1016/S0166-4115(08)61146-2 CrossRefPubMed

Hayes AF (2013) Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. Guilford, New York

Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil O, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, JA MC, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, for the CHARTER Group (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy. Neurology 75(23):2087–2096. https://doi.org/10.1212/WNL.0b013e318200d727 CrossRefPubMedPubMedCentral

Heaton RK, Franklin DR Jr, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, Atkinson JH, Marcotte TD, McCutchan JA, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, Abramson I, Gamst AC, Fennema-Notestine C, Smith DM, Grant I, CHARTER Group (2015) Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinalCHARTER study. Clin Infect Dis 60(3):473–480. https://doi.org/10.1093/cid/ciu862 CrossRefPubMed

Holt JL, Kraft-Terry SD, Chang L (2012) Neuroimaging studies of the aging HIV-1-infected brain. J Neuro-Oncol 18(4):291–302. https://doi.org/10.1007/s13365-012-0114-1 CrossRef

Hong S, Banks WA (2015) Role of the immune system in HIV-asociated neuroinflammation and neurocognitive implications. Brain Behav Immun 45:1–12. https://doi.org/10.1016/j.bbi.2014.10.008 CrossRefPubMed

Hua X, Boyle CP, Harezlak J, Tate DF, Yiannoutsos CT, Cohen R, Schifitto G, Gongvatana A, Zhong J, Zhu T, Taylor MJ, Campbell TB, Daar ES, Alger JR, Singer E, Buchthal S, Toga AW, Navia B, Thompson PM, the HIV Neuroimaging Consortium (2013) Disrupted cerebral metabolite levels and lower nadir CD4+ counts are linked to brain volume deficits in 210 HIV-infected patients on stable treatment. Neuroimage Clin 3(2013):132–142. https://doi.org/10.1016/j.nicl.2013.07.009

Jaworowska A (2002) Wisconsin card sorting Tes manual. Psychological Test Laboratory of the Polish Psychological Association, Warsaw

Jerningan TL, Archibald SL, Fennema-Notestine C, Taylor MJ, Theilmann RJ, Julaton MD, Notestine RJ, Wolfson T, Letendre SL, Ellis RJ, Heaton RK, Gamst AC, Franklin DR Jr, Clifford DB, Collier AC, Gelman BB, Marra C, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I, for the CHARTER Group (2011) Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol 17(3):248–257. https://doi.org/10.1007/s13365-011-0032-7 CrossRef

Küper MK, Rabe S, Esser E, Gizewski E, Husstedt IW, Maschke M, Obermann M (2011) Structural gray and white matter changes in patients with HIV. J Neurol 258:1066–1075. https://doi.org/10.1007/s00415-010-5883-y CrossRefPubMed

Łojek E, Stańczak J (2005) RFFT. Ruff Figural Fluency Test. Psychological Test Laboratory of the Polish Psychological Association, Warsaw

Łojek E, Stańczak J (2010) California Verbal Learning Test. Polish normalisation. Psychological Test Laboratory of the Polish Psychological Association, Warsaw

Łojek E, Stańczak J (2012) CTT – colour trails test adult version. Psychological Test Laboratory of the Polish Psychological Association, Warsaw

McCombe JA, Vivithanaporn P, Gill MJ, Power C (2013) Predictors of symptomatic HIV-associated neurocognitive disorders in universal health care. HIV Med 14(2):99–107. https://doi.org/10.1111/j.1468-1293.2012.01043.x CrossRefPubMed

McDonnell J, Haddow L, Daskalapoulou M, Lampe F, Speakman A, Gilson R, Philips A, Sherr L, Wayal S, Harrison J, Antinori A, Maruff P, Schembri A, Johnson M, Collins S, Rodger A (2014) Minimal cognitive impariment in UK HIV-positive men who have sex with men: effect of case definitions and comparison with the general population and HIV-negative men. J Acquir Immune Defic Syndr 67(2):120–127. https://doi.org/10.1097/QAI.0000000000000273 CrossRefPubMedPubMedCentral

Muñoz-Moreno JA, Fumaz CR, Ferrer MJ, Prats A, Negredo E, Garolera M, Pérez-Alvarez N, Moltó J, Gómez G, Clotet B (2008) Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients. AIDS Res Hum Retrovir 24(10):1301–1307. https://doi.org/10.1089/aid.2007.0310 CrossRefPubMed

Ortega M, Brier MR, Ances BM (2015) Effects of HIV and combination antiretroviral therapy (cART) on cortico-striatal functional connectivity. AIDS 29(6):703–712. https://doi.org/10.1097/QAD.0000000000000611 CrossRefPubMed

Pfefferbaum A, Rogosa DA, Rosenbloom MJ, Chu W, Sassoon SA, Kemper CA, Deresinski S, Rohlfing T, Zahr NM, Sullivan EV (2014) Accelerated aging of selective brain structures in HIV infection: a controlled, longitudinal MRI study. Neurobiol Aging 35(7):1755–1768. https://doi.org/10.1016/j.neurobiolaging.2014.01.008 CrossRefPubMedPubMedCentral

Pluta A, Wolak T, Sobańska M, Gawron N, Egbert A R, Szymańska B, Horban A, Firląg-Burkacka E, Bieńkowski P, Sienkiewicz-Jarosz H, Ścińska-Bieńkowska A, Desowska A, Rusiniak M, Biswal B B, Rao S, Bornstein R, Skarżyński H, Łojek E (in press) HIV and age underlie specific patterns of brain abnormalities and cognitive changes in high functioning patients

Saktor N, Skolasky RL, Cox C, Selnes O, Becker JT, Cohen B, Martin E, Miller EN, Multicenter AIDS Cohort Study (MACS) (2010) Longitudinal psychomotor speed performance in human immunodeficiency virus-seropositive individuals: impact of age and serostatus. J Neurovirol 16(5):335–341. https://doi.org/10.3109/13550284.2010.504249 CrossRef

Sanford R, Fernandez Cruz AL, Scott SC, Mayo NE, Fellows LK, Ances BM, Collins DL (2017) Regionally specific brain volumetric and cortical thickness changes in HIV-infected patients in the HAART era. J Acquir Immune Defic Syndr 74(5):563–570. https://doi.org/10.1097/QAI.0000000000001294 CrossRefPubMedPubMedCentral

Seider TR, Gongvatana A, Woods AJ, Chen H, Porges EC, Cummings T, Correia S, Tashima K, Cohen RA (2016) Age exacerbates HIV-associated white matter abnormalities. J Neuro-Oncol 22:201–212. https://doi.org/10.1007/s13365-015-0386-3 CrossRef

Seider TR, Luo X, Gongvatana A, Devlin KN, de la Monte SM, Chasman JD, Yan P, Tashima KT, Navia B, Cohen RA (2014) Verbal memory declines more rapidly with age in HIV infected versus uninfected adults. J Clin Exp Neuropsychol 36(4):356–367. https://doi.org/10.1080/13803395.2014.892061 CrossRefPubMedPubMedCentral

Sheppard DP, Woods SP, Bondi MW, Gilbert PE, Massman PJ, Doyle KL, HIV Neurobehavioral Research Program Group (2015) Does older age confer an increased risk of incident neurocognitive disorders among persons living with HIV disease? Clin Neuropsychol 29(5):656–677. https://doi.org/10.1080/13854046.2015.1077995 CrossRefPubMedPubMedCentral

Simioni S, Cavassini M, Annoni J-M, Rimbault Abraham A, Bourquin I, Schiffer V, Calmy A, Chave J-P, Giacobini E, Hirschel B, Du Pasquier RA (2010) Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 24:1243–1250. https://doi.org/10.1097/QAD.0b013e3283354a7b CrossRefPubMed

Stańczak J (2010) MMSE. Mini-mental State Examination. Psychological Test Laboratory of the Polish Psychological Association, Warsaw

Su T, Wit FW, Caan MW, Schouten J, Prins M, Geurtsen GJ, Cole JH, Sharp DJ, Richard E, Reneman L, Portegies P, Reiss P, Majoie CB, Cohort Study AGEIV (2016) White matter hyperintensities in relation to cognition in HIV-infected men with sustainedsuppressed viral load on combination antiretroviral therapy. AIDS 30(15):2329–2339. https://doi.org/10.1097/QAD.0000000000001133 CrossRefPubMed

Szepietowska EM, Gawda B (2011) Ścieżkami fluencji werbalnej. UMCS, Lublin

Tavoschi L, Gomes Dias J, Pharris A, EU/EEA HIV Surveillance Network (2017) New HIV diagnoses among adults aged 50 years or older in 31 European countries, 2004-15: an analysis of surveillance data. Lancet HIV 4(11):e514–e521. https://doi.org/10.1016/S2352-3018(17)30155-8 CrossRefPubMed

Towgood KJ, Pitkanen M, Kulasegaram R, Fradera A, Kumar A, Soni S, Sibtain NA, Reed L, Bradbeer C, Barker GJ, Kopelman MD (2012) Mapping the brain in younger and older asymptomatic HIV-1 men: frontal volume changes in the absence of other cortical or diffusion tensor abnormalities. Cortex 48:230–241CrossRefPubMed

Valcour V, Paul R, Neuhaus J, Shikuma C (2011) The effects of age and HIV on neuropsychological performance. J Int Neuropsychol Soc 17(1):190–195. https://doi.org/10.1017/S1355617710001438 CrossRefPubMed

Valcour V, Yee P, Williams AE, Shiramizu B, Watters M, Selnes O, Paul R, Shikuma C, Sacktor N (2006) Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection—the Hawaii Aging with HIV Cohort. J Neuro-Oncol 12:387–391. https://doi.org/10.1080/13550280600915339 CrossRef

van den Dries LWJ, Wagener MN, Jiskoot LC, Visser M, Robertson KR, Adriani KS, van Gorp ECM (2017) Neurocognitive impairment in a chronically well-suppressed HIV-infected population: the Dutch TREVI Cohort Study. AIDS Patient Care STDs 31(8):329–334. https://doi.org/10.1089/apc.2017.0038 CrossRefPubMed

Walker KA, Brown GG (2017) HIV-associated executive dysfunction in the era of modern antiretroviral therapy: a systematic review and meta-analysis. J Clin Exp Neuropsychol 9:1–20. https://doi.org/10.1080/13803395.2017.1349879 CrossRef

Wright PW, Pyakurel A, Vaida FF, Price RW, Lee E, Peterson J, Fuchs D, Zetterberg H, Robertson KR, Walter R, Meyerhoff DJ, Spudich SS, Ances BM (2016) Putamen volume and its clinical and neurological correlates in primary HIV infection. AIDS 30(11):1789–1794. https://doi.org/10.1097/QAD.0000000000001103 CrossRefPubMed

Title: Effects of age, HIV, and HIV-associated clinical factors on neuropsychological functioning and brain regional volume in HIV+ patients on effective treatment
Authors: Natalia Gawron
M. Choiński
B. Szymańska-Kotwica
A. Pluta
M. Sobańska
A. R. Egbert
A. Desowska
T. Wolak
A. Horban
E. Firląg-Burkacka
P. Bieńkowski
H. Sienkiewicz-Jarosz
A. Scińska-Bieńkowska
B. Biswal
S. M. Rao
R. Bornstein
E. Łojek
Publication date: 01-02-2019
Publisher: Springer International Publishing
Published in: Journal of NeuroVirology / Issue 1/2019
Print ISSN: 1355-0284
Electronic ISSN: 1538-2443
DOI: https://doi.org/10.1007/s13365-018-0679-4

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Effects of age, HIV, and HIV-associated clinical factors on neuropsychological functioning and brain regional volume in HIV+ patients on effective treatment

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2019

Herpes zoster increased risk of neuralgic amyotrophy: a retrospective, population-based matched cohort study

Recurrent strokes, central nervous system vasculitis, and acquired protein S deficiency secondary to varicella zoster in a child with AIDS

Multimodal techniques failed to detect cytomegalovirus in human glioblastoma samples

The bovine herpesvirus 1 regulatory proteins, bICP4 and bICP22, are expressed during the escape from latency

Enhanced facilitation and diminished inhibition characterizes the pronociceptive endogenous pain modulatory balance of persons living with HIV and chronic pain

HERV-W env regulates calcium influx via activating TRPC3 channel together with depressing DISC1 in human neuroblastoma cells